Helicobacter pylori‐related diseases
- 1 May 2001
- journal article
- research article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 31 (5) , 431-437
- https://doi.org/10.1046/j.1365-2362.2001.00835.x
Abstract
No abstract availableThis publication has 79 references indexed in Scilit:
- Interleukin-1 polymorphisms associated with increased risk of gastric cancerNature, 2000
- Costs and benefits of a test-and-treat strategy in Helicobacter pylori-infected subjectsEuropean Journal of Gastroenterology & Hepatology, 2000
- Relation between clinical presentation, Helicobacter pylori density, interleukin 1beta and 8 production, and cagA statusGut, 1999
- Absence of Benefit of EradicatingHelicobacter pyloriin Patients with Nonulcer DyspepsiaNew England Journal of Medicine, 1999
- Regression of duodenal mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pyloriGastroenterology, 1996
- Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infectionThe Lancet, 1995
- Neutrophil degranulation by Helicobacter pylori proteins.Gut, 1995
- Serum Gastrin and Mucosal Somatostatin inHelicobacterpylori-Associated GastritisScandinavian Journal of Gastroenterology, 1995
- Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite production in vivo.Gut, 1994
- Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pyloriThe Lancet, 1993